Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
IPO Year:
Exchange: NASDAQ
Website: kewaunee.com
| Date | Price Target | Rating | Analyst |
|---|
SCHEDULE 13D/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
8-K/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
144 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
144 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
STATESVILLE, N.C., Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its second quarter ended October 31, 2024. Fiscal Year 2025 Second Quarter Results: Sales during the second quarter of fiscal year 2025 were $47,764,000, a decrease of 5.3% compared to sales of $50,436,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,931,000 compared to $4,845,000 for the prior year quarter, a decrease of 18.9%. Net earnings were $3,008,000 compared to net earnings of $2,732,000 for the prior year quarter.
STATESVILLE, N.C., Nov. 27, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its second quarter fiscal year 2025 financial results on Wednesday, December 11, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Nu Aire Founded in 1971 and based in Minneapolis, the Company is a leading manufacturer of equipment for a diverse range of laboratory and pharmacy environments. Nu Aire is the North American market share leader in biologi
STATESVILLE, N.C., Nov. 1, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) Kewaunee Scientific Corporation ("Kewaunee"), a leader in laboratory furniture and technical product design and manufacturing, today announced the successful acquisition of Nu Aire, a Minneapolis-based company, for $55 million, subject to certain adjustments for debt, cash, transaction expenses, and net working capital. Nu Aire is renowned for its manufacturing of biological safety cabinets, airflow products, CO2 incubators, ultralow freezers, animal handling equipment, pharmacy compo
STATESVILLE, N.C., Sept. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its first quarter ended July 31, 2024. Fiscal Year 2025 First Quarter Results: Sales during the first quarter of fiscal year 2025 were $48,393,000, a decrease of 2.9% compared to sales of $49,839,000 from the prior year's first quarter. Pre-tax earnings for the quarter were $2,430,000 compared to $3,412,000 for the prior year quarter, a decrease of 28.8%. Net earnings were $2,193,000 compared to net earnings of $2,474,000 for the prior year quarter. EBITD
STATESVILLE, N.C., Sept. 4, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announces that the Company will attend the 2024 Arablab Live tradeshow and conference being held in Dubai this September 24-26. The tradeshow will welcome industry professionals from 120+ countries, bringing together leading global designers, manufacturers, and distributors in fields ranging from life sciences to clean energy, industrial, chemical, and more.
STATESVILLE, N.C., Aug. 28, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its first quarter fiscal year 2025 financial results on Wednesday, September 11, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's pr
STATESVILLE, N.C., June 26, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2024. Fiscal Year 2024 Fourth Quarter Results: Sales during the fourth quarter of fiscal year 2024 were $56,702,000, an increase of 5% compared to sales of $53,986,000 from the prior year's fourth quarter. Pre-tax earnings for the quarter were $1,347,000 compared to $2,322,000 for the prior year quarter. Net earnings for the quarter were $11,026,000 compared to net earnings of $1,005,000 for the prior
STATESVILLE, N.C., June 12, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2024 on Wednesday, June 26, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture produc
STATESVILLE, N.C., March 6, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its third quarter ended January 31, 2024. Fiscal Year 2024 Third Quarter Results: Sales during the third quarter of fiscal year 2024 were $46,778,000, a decrease of 23.1% compared to sales of $60,821,000 from the prior year's third quarter. Pre-tax earnings for the quarter were $3,515,000 compared to $2,060,000 for the prior year quarter, an increase of 70.6%. Net earnings were $2,521,000 compared to net earnings of $723,000 for the prior year quarter. EBI
STATESVILLE, N.C., Feb. 21, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its third quarter fiscal year 2024 financial results on Wednesday, March 6, 2024 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's product
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
STATESVILLE, N.C., Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its second quarter ended October 31, 2024. Fiscal Year 2025 Second Quarter Results: Sales during the second quarter of fiscal year 2025 were $47,764,000, a decrease of 5.3% compared to sales of $50,436,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,931,000 compared to $4,845,000 for the prior year quarter, a decrease of 18.9%. Net earnings were $3,008,000 compared to net earnings of $2,732,000 for the prior year quarter.
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13D/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13D/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G/A - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13D - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
SC 13G - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)